echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > To save his brother's life, Harvard graduates tailored gene therapy for him

    To save his brother's life, Harvard graduates tailored gene therapy for him

    • Last Update: 2022-09-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    ▎ WuXi AppTec content team editor

    On August 9, 2022, Cure Rare Disease (CRD), a Boston-based nonprofit organization, announced that the FDA had approved its IND application for a CRISPR gene-edited therapy called CRD-TMH-001 for the treatment of Duchenne muscular dystrophy (DMD



    Richard Hogan (Image source: Cure Rare Disease official website)


    In 2019, he teamed up with the University of Massachusetts School of Medicine, Yale University, and other institutions to build a team


    Terry's condition was also caused



    Image credit: 123RF


    To reduce the body's response to the virus, Terry also needs to take immunosuppressants


    As WuXi AppTec's CTDMO focused on cell and gene therapies, WuXi Biotech is committed to accelerating and transforming the development, testing, production and commercialization of gene and cell therapies and other high-end therapies


    ▲If you have any business needs, please long press to scan the QR code above, or

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.